Ivonescimab (AK112) is a bispecific antibody targeting both PD-1 and VEGF, designed for advanced applications in cancer research. This dual-targeting mechanism facilitates the simultaneous inhibition of immune checkpoint pathways and angiogenesis, making it a valuable tool for investigating tumor microenvironment interactions and therapeutic strategies in oncology.
Ivonescimab (AK112) is a bispecific antibody targeting both PD-1 and VEGF, designed for advanced applications in cancer research. This dual-targeting mechanism facilitates the simultaneous inhibition of immune checkpoint pathways and angiogenesis, making it a valuable tool for investigating tumor microenvironment interactions and therapeutic strategies in oncology.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
